Literature DB >> 32681249

Vascular Metabolic Mechanisms of Pulmonary Hypertension.

Xiao-Fan Shi1, Yun-Chao Su2,3,4.   

Abstract

Pulmonary hypertension (PH) is a severe and progressive disease characterized by increased pulmonary vascular resistance leading to right heart failure and death. In PH, the cellular metabolisms including those of the three major nutrients (carbohydrate, lipid and protein) are aberrant in pulmonary vascular cells. Glucose uptake, glycolysis, insulin resistance, sphingolipid S1P, PGE2, TXA2, leukotrienes and glutaminolysis are upregulated, and phospholipid-prostacyclin and L-arginine-nitric oxide pathway are compromised in lung vascular cells. Fatty acid metabolism is disordered in lung endothelial cells and smooth muscle cells. These molecular mechanisms are integrated to promote PH-specific abnormal vascular cell proliferation and vascular remodeling. This review summarizes the recent advances in the metabolic reprogramming of glucose, fatty acid, and amino acid metabolism in pulmonary vascular remodeling in PH and the mechanisms for how these alterations affect vascular cell fate and impact the course of PH.

Entities:  

Keywords:  metabolism; proliferation; pulmonary hypertension; vascular remodeling

Mesh:

Year:  2020        PMID: 32681249     DOI: 10.1007/s11596-020-2198-9

Source DB:  PubMed          Journal:  Curr Med Sci        ISSN: 2523-899X


  114 in total

Review 1.  Endothelial dysfunction in pulmonary hypertension.

Authors:  Rohit Budhiraja; Rubin M Tuder; Paul M Hassoun
Journal:  Circulation       Date:  2004-01-20       Impact factor: 29.690

2.  Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension.

Authors:  R B Rothman; M A Ayestas; C M Dersch; M H Baumann
Journal:  Circulation       Date:  1999-08-24       Impact factor: 29.690

3.  Shear stress-induced Ang II AT1 receptor activation: G-protein dependent and independent mechanisms.

Authors:  Valerio G Barauna; Flávio C Magalhaes; Luciene C G Campos; Rosana I Reis; Satya P Kunapuli; Claudio M Costa-Neto; Ayumi A Miyakawa; Jose E Krieger
Journal:  Biochem Biophys Res Commun       Date:  2013-04-11       Impact factor: 3.575

Review 4.  Updated clinical classification of pulmonary hypertension.

Authors:  Gerald Simonneau; Michael A Gatzoulis; Ian Adatia; David Celermajer; Chris Denton; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; R Krishna Kumar; Michael Landzberg; Roberto F Machado; Horst Olschewski; Ivan M Robbins; Rogiero Souza
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

5.  The New World Symposium on Pulmonary Hypertension Guidelines: Should Twenty-One Be the New Twenty-Five?

Authors:  Nicole F Ruopp; Harrison W Farber
Journal:  Circulation       Date:  2019-09-30       Impact factor: 29.690

6.  Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.

Authors:  K B Lane; R D Machado; M W Pauciulo; J R Thomson; J A Phillips; J E Loyd; W C Nichols; R C Trembath
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

7.  Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia.

Authors:  R E Harrison; J A Flanagan; M Sankelo; S A Abdalla; J Rowell; R D Machado; C G Elliott; I M Robbins; H Olschewski; V McLaughlin; E Gruenig; F Kermeen; M Halme; A Räisänen-Sokolowski; T Laitinen; N W Morrell; R C Trembath
Journal:  J Med Genet       Date:  2003-12       Impact factor: 6.318

8.  Causes and circumstances of death in pulmonary arterial hypertension.

Authors:  Adriano R Tonelli; Vineesha Arelli; Omar A Minai; Jennie Newman; Nancy Bair; Gustavo A Heresi; Raed A Dweik
Journal:  Am J Respir Crit Care Med       Date:  2013-08-01       Impact factor: 21.405

9.  An overview of the 6th World Symposium on Pulmonary Hypertension.

Authors:  Nazzareno Galiè; Vallerie V McLaughlin; Lewis J Rubin; Gerald Simonneau
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

Review 10.  Mechanisms of disease: pulmonary arterial hypertension.

Authors:  Ralph T Schermuly; Hossein A Ghofrani; Martin R Wilkins; Friedrich Grimminger
Journal:  Nat Rev Cardiol       Date:  2011-06-21       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.